角膜移植拒絶反応治療薬の世界市場（～2026年）

• 英文タイトル：Global Corneal Graft Rejection Drug Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY00670 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は角膜移植拒絶反応治療薬のグローバル市場について調査・分析したレポートです。種類別（OXB-202、GB-301、Cyndacel-M、VGX-100、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別角膜移植拒絶反応治療薬の競争状況、市場シェア ・世界の角膜移植拒絶反応治療薬市場：種類別市場規模 2015年-2020年（OXB-202、GB-301、Cyndacel-M、VGX-100、その他） ・世界の角膜移植拒絶反応治療薬市場：種類別市場規模予測 2021年-2026年（OXB-202、GB-301、Cyndacel-M、VGX-100、その他） ・世界の角膜移植拒絶反応治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の角膜移植拒絶反応治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の角膜移植拒絶反応治療薬市場分析：米国、カナダ ・ヨーロッパの角膜移植拒絶反応治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの角膜移植拒絶反応治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の角膜移植拒絶反応治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの角膜移植拒絶反応治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Circadian Technologies Limited、Gene Signal International SA、Oxford BioMedica Plc、Santen Pharmaceutical Co., Ltd. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Corneal Graft Rejection Drug Market
The global Corneal Graft Rejection Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Corneal Graft Rejection Drug Scope and Market Size
Corneal Graft Rejection Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Corneal Graft Rejection Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Corneal Graft Rejection Drug market is segmented into
OXB-202
GB-301
Cyndacel-M
VGX-100
Others

Segment by Application, the Corneal Graft Rejection Drug market is segmented into
Hospital
Clinic
Others

Regional and Country-level Analysis
The Corneal Graft Rejection Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Corneal Graft Rejection Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Corneal Graft Rejection Drug Market Share Analysis
Corneal Graft Rejection Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Corneal Graft Rejection Drug business, the date to enter into the Corneal Graft Rejection Drug market, Corneal Graft Rejection Drug product introduction, recent developments, etc.

The major vendors covered:
Circadian Technologies Limited
Gene Signal International SA
Oxford BioMedica Plc
Santen Pharmaceutical Co., Ltd.
…

レポート目次

---

1 Study Coverage
1.1 Corneal Graft Rejection Drug Product Introduction
1.2 Market Segments
1.3 Key Corneal Graft Rejection Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Corneal Graft Rejection Drug Market Size Growth Rate by Type
1.4.2 OXB-202
1.4.3 GB-301
1.4.4 Cyndacel-M
1.4.5 VGX-100
1.4.6 Others
1.5 Market by Application
1.5.1 Global Corneal Graft Rejection Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Corneal Graft Rejection Drug Market Size, Estimates and Forecasts
2.1.1 Global Corneal Graft Rejection Drug Revenue 2015-2026
2.1.2 Global Corneal Graft Rejection Drug Sales 2015-2026
2.2 Global Corneal Graft Rejection Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Corneal Graft Rejection Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Corneal Graft Rejection Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Corneal Graft Rejection Drug Competitor Landscape by Players
3.1 Corneal Graft Rejection Drug Sales by Manufacturers
3.1.1 Corneal Graft Rejection Drug Sales by Manufacturers (2015-2020)
3.1.2 Corneal Graft Rejection Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Corneal Graft Rejection Drug Revenue by Manufacturers
3.2.1 Corneal Graft Rejection Drug Revenue by Manufacturers (2015-2020)
3.2.2 Corneal Graft Rejection Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Corneal Graft Rejection Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Corneal Graft Rejection Drug Revenue in 2019
3.2.5 Global Corneal Graft Rejection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Corneal Graft Rejection Drug Price by Manufacturers
3.4 Corneal Graft Rejection Drug Manufacturing Base Distribution, Product Types
3.4.1 Corneal Graft Rejection Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Corneal Graft Rejection Drug Product Type
3.4.3 Date of International Manufacturers Enter into Corneal Graft Rejection Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Corneal Graft Rejection Drug Market Size by Type (2015-2020)
4.1.1 Global Corneal Graft Rejection Drug Sales by Type (2015-2020)
4.1.2 Global Corneal Graft Rejection Drug Revenue by Type (2015-2020)
4.1.3 Corneal Graft Rejection Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Corneal Graft Rejection Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Corneal Graft Rejection Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Corneal Graft Rejection Drug Revenue Forecast by Type (2021-2026)
4.2.3 Corneal Graft Rejection Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Corneal Graft Rejection Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Corneal Graft Rejection Drug Market Size by Application (2015-2020)
5.1.1 Global Corneal Graft Rejection Drug Sales by Application (2015-2020)
5.1.2 Global Corneal Graft Rejection Drug Revenue by Application (2015-2020)
5.1.3 Corneal Graft Rejection Drug Price by Application (2015-2020)
5.2 Corneal Graft Rejection Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Corneal Graft Rejection Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Corneal Graft Rejection Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Corneal Graft Rejection Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America Corneal Graft Rejection Drug by Country
6.1.1 North America Corneal Graft Rejection Drug Sales by Country
6.1.2 North America Corneal Graft Rejection Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Corneal Graft Rejection Drug Market Facts & Figures by Type
6.3 North America Corneal Graft Rejection Drug Market Facts & Figures by Application

7 Europe
7.1 Europe Corneal Graft Rejection Drug by Country
7.1.1 Europe Corneal Graft Rejection Drug Sales by Country
7.1.2 Europe Corneal Graft Rejection Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Corneal Graft Rejection Drug Market Facts & Figures by Type
7.3 Europe Corneal Graft Rejection Drug Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Corneal Graft Rejection Drug by Region
8.1.1 Asia Pacific Corneal Graft Rejection Drug Sales by Region
8.1.2 Asia Pacific Corneal Graft Rejection Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Corneal Graft Rejection Drug Market Facts & Figures by Type
8.3 Asia Pacific Corneal Graft Rejection Drug Market Facts & Figures by Application

9 Latin America
9.1 Latin America Corneal Graft Rejection Drug by Country
9.1.1 Latin America Corneal Graft Rejection Drug Sales by Country
9.1.2 Latin America Corneal Graft Rejection Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Corneal Graft Rejection Drug Market Facts & Figures by Type
9.3 Central & South America Corneal Graft Rejection Drug Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Corneal Graft Rejection Drug by Country
10.1.1 Middle East and Africa Corneal Graft Rejection Drug Sales by Country
10.1.2 Middle East and Africa Corneal Graft Rejection Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Corneal Graft Rejection Drug Market Facts & Figures by Type
10.3 Middle East and Africa Corneal Graft Rejection Drug Market Facts & Figures by Application

11 Company Profiles
11.1 Circadian Technologies Limited
11.1.1 Circadian Technologies Limited Corporation Information
11.1.2 Circadian Technologies Limited Description and Business Overview
11.1.3 Circadian Technologies Limited Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Circadian Technologies Limited Corneal Graft Rejection Drug Products Offered
11.1.5 Circadian Technologies Limited Related Developments
11.2 Gene Signal International SA
11.2.1 Gene Signal International SA Corporation Information
11.2.2 Gene Signal International SA Description and Business Overview
11.2.3 Gene Signal International SA Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Gene Signal International SA Corneal Graft Rejection Drug Products Offered
11.2.5 Gene Signal International SA Related Developments
11.3 Oxford BioMedica Plc
11.3.1 Oxford BioMedica Plc Corporation Information
11.3.2 Oxford BioMedica Plc Description and Business Overview
11.3.3 Oxford BioMedica Plc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Oxford BioMedica Plc Corneal Graft Rejection Drug Products Offered
11.3.5 Oxford BioMedica Plc Related Developments
11.4 Santen Pharmaceutical Co., Ltd.
11.4.1 Santen Pharmaceutical Co., Ltd. Corporation Information
11.4.2 Santen Pharmaceutical Co., Ltd. Description and Business Overview
11.4.3 Santen Pharmaceutical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Santen Pharmaceutical Co., Ltd. Corneal Graft Rejection Drug Products Offered
11.4.5 Santen Pharmaceutical Co., Ltd. Related Developments
11.1 Circadian Technologies Limited
11.1.1 Circadian Technologies Limited Corporation Information
11.1.2 Circadian Technologies Limited Description and Business Overview
11.1.3 Circadian Technologies Limited Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Circadian Technologies Limited Corneal Graft Rejection Drug Products Offered
11.1.5 Circadian Technologies Limited Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Corneal Graft Rejection Drug Market Estimates and Projections by Region
12.1.1 Global Corneal Graft Rejection Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Corneal Graft Rejection Drug Revenue Forecast by Regions 2021-2026
12.2 North America Corneal Graft Rejection Drug Market Size Forecast (2021-2026)
12.2.1 North America: Corneal Graft Rejection Drug Sales Forecast (2021-2026)
12.2.2 North America: Corneal Graft Rejection Drug Revenue Forecast (2021-2026)
12.2.3 North America: Corneal Graft Rejection Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Corneal Graft Rejection Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Corneal Graft Rejection Drug Sales Forecast (2021-2026)
12.3.2 Europe: Corneal Graft Rejection Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Corneal Graft Rejection Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Corneal Graft Rejection Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Corneal Graft Rejection Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Corneal Graft Rejection Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Corneal Graft Rejection Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Corneal Graft Rejection Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Corneal Graft Rejection Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Corneal Graft Rejection Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Corneal Graft Rejection Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Corneal Graft Rejection Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Corneal Graft Rejection Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Corneal Graft Rejection Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Corneal Graft Rejection Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Corneal Graft Rejection Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Corneal Graft Rejection Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Corneal Graft Rejection Drug Market Segments
Table 2. Ranking of Global Top Corneal Graft Rejection Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Corneal Graft Rejection Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of OXB-202
Table 5. Major Manufacturers of GB-301
Table 6. Major Manufacturers of Cyndacel-M
Table 7. Major Manufacturers of VGX-100
Table 8. Major Manufacturers of Others
Table 9. Global Corneal Graft Rejection Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Corneal Graft Rejection Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Corneal Graft Rejection Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Corneal Graft Rejection Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Corneal Graft Rejection Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Corneal Graft Rejection Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Corneal Graft Rejection Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Corneal Graft Rejection Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Corneal Graft Rejection Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Corneal Graft Rejection Drug as of 2019)
Table 18. Corneal Graft Rejection Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Corneal Graft Rejection Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Corneal Graft Rejection Drug Price (2015-2020) (USD/Pcs)
Table 21. Corneal Graft Rejection Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Corneal Graft Rejection Drug Product Type
Table 23. Date of International Manufacturers Enter into Corneal Graft Rejection Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Corneal Graft Rejection Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Corneal Graft Rejection Drug Sales Share by Type (2015-2020)
Table 27. Global Corneal Graft Rejection Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Corneal Graft Rejection Drug Revenue Share by Type (2015-2020)
Table 29. Corneal Graft Rejection Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Corneal Graft Rejection Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Corneal Graft Rejection Drug Sales Share by Application (2015-2020)
Table 32. North America Corneal Graft Rejection Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Corneal Graft Rejection Drug Sales Market Share by Country (2015-2020)
Table 34. North America Corneal Graft Rejection Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Corneal Graft Rejection Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Corneal Graft Rejection Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Corneal Graft Rejection Drug Sales Market Share by Type (2015-2020)
Table 38. North America Corneal Graft Rejection Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Corneal Graft Rejection Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Corneal Graft Rejection Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Corneal Graft Rejection Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Corneal Graft Rejection Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Corneal Graft Rejection Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Corneal Graft Rejection Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Corneal Graft Rejection Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Corneal Graft Rejection Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Corneal Graft Rejection Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Corneal Graft Rejection Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Corneal Graft Rejection Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Corneal Graft Rejection Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Corneal Graft Rejection Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Corneal Graft Rejection Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Corneal Graft Rejection Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Corneal Graft Rejection Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Corneal Graft Rejection Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Corneal Graft Rejection Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Corneal Graft Rejection Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Corneal Graft Rejection Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Corneal Graft Rejection Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Corneal Graft Rejection Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Corneal Graft Rejection Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Corneal Graft Rejection Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Corneal Graft Rejection Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Corneal Graft Rejection Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Corneal Graft Rejection Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Corneal Graft Rejection Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Corneal Graft Rejection Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Corneal Graft Rejection Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Corneal Graft Rejection Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Corneal Graft Rejection Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Corneal Graft Rejection Drug Sales Market Share by Application (2015-2020)
Table 72. Circadian Technologies Limited Corporation Information
Table 73. Circadian Technologies Limited Description and Major Businesses
Table 74. Circadian Technologies Limited Corneal Graft Rejection Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Circadian Technologies Limited Product
Table 76. Circadian Technologies Limited Recent Development
Table 77. Gene Signal International SA Corporation Information
Table 78. Gene Signal International SA Description and Major Businesses
Table 79. Gene Signal International SA Corneal Graft Rejection Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Gene Signal International SA Product
Table 81. Gene Signal International SA Recent Development
Table 82. Oxford BioMedica Plc Corporation Information
Table 83. Oxford BioMedica Plc Description and Major Businesses
Table 84. Oxford BioMedica Plc Corneal Graft Rejection Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Oxford BioMedica Plc Product
Table 86. Oxford BioMedica Plc Recent Development
Table 87. Santen Pharmaceutical Co., Ltd. Corporation Information
Table 88. Santen Pharmaceutical Co., Ltd. Description and Major Businesses
Table 89. Santen Pharmaceutical Co., Ltd. Corneal Graft Rejection Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Santen Pharmaceutical Co., Ltd. Product
Table 91. Santen Pharmaceutical Co., Ltd. Recent Development
Table 92. Global Corneal Graft Rejection Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 93. Global Corneal Graft Rejection Drug Sales Market Share Forecast by Regions (2021-2026)
Table 94. Global Corneal Graft Rejection Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 95. Global Corneal Graft Rejection Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 96. North America: Corneal Graft Rejection Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 97. North America: Corneal Graft Rejection Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Europe: Corneal Graft Rejection Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 99. Europe: Corneal Graft Rejection Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Asia Pacific: Corneal Graft Rejection Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 101. Asia Pacific: Corneal Graft Rejection Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 102. Latin America: Corneal Graft Rejection Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Latin America: Corneal Graft Rejection Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Middle East and Africa: Corneal Graft Rejection Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. Middle East and Africa: Corneal Graft Rejection Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 107. Key Challenges
Table 108. Market Risks
Table 109. Main Points Interviewed from Key Corneal Graft Rejection Drug Players
Table 110. Corneal Graft Rejection Drug Customers List
Table 111. Corneal Graft Rejection Drug Distributors List
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Corneal Graft Rejection Drug Product Picture
Figure 2. Global Corneal Graft Rejection Drug Sales Market Share by Type in 2020 & 2026
Figure 3. OXB-202 Product Picture
Figure 4. GB-301 Product Picture
Figure 5. Cyndacel-M Product Picture
Figure 6. VGX-100 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Corneal Graft Rejection Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Corneal Graft Rejection Drug Report Years Considered
Figure 13. Global Corneal Graft Rejection Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Corneal Graft Rejection Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Corneal Graft Rejection Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Corneal Graft Rejection Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Corneal Graft Rejection Drug Sales Market Share by Region in 2019
Figure 18. Global Corneal Graft Rejection Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Corneal Graft Rejection Drug Revenue Market Share by Region in 2019
Figure 20. Global Corneal Graft Rejection Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Corneal Graft Rejection Drug Revenue in 2019
Figure 22. Corneal Graft Rejection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Corneal Graft Rejection Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Corneal Graft Rejection Drug Sales Market Share by Type in 2019
Figure 25. Global Corneal Graft Rejection Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Corneal Graft Rejection Drug Revenue Market Share by Type in 2019
Figure 27. Global Corneal Graft Rejection Drug Market Share by Price Range (2015-2020)
Figure 28. Global Corneal Graft Rejection Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Corneal Graft Rejection Drug Sales Market Share by Application in 2019
Figure 30. Global Corneal Graft Rejection Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Corneal Graft Rejection Drug Revenue Market Share by Application in 2019
Figure 32. North America Corneal Graft Rejection Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Corneal Graft Rejection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Corneal Graft Rejection Drug Sales Market Share by Country in 2019
Figure 35. North America Corneal Graft Rejection Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Corneal Graft Rejection Drug Market Share by Type in 2019
Figure 41. North America Corneal Graft Rejection Drug Market Share by Application in 2019
Figure 42. Europe Corneal Graft Rejection Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Corneal Graft Rejection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Corneal Graft Rejection Drug Sales Market Share by Country in 2019
Figure 45. Europe Corneal Graft Rejection Drug Revenue Market Share by Country in 2019
Figure 46. Germany Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Corneal Graft Rejection Drug Market Share by Type in 2019
Figure 57. Europe Corneal Graft Rejection Drug Market Share by Application in 2019
Figure 58. Asia Pacific Corneal Graft Rejection Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Corneal Graft Rejection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Corneal Graft Rejection Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Corneal Graft Rejection Drug Revenue Market Share by Region in 2019
Figure 62. China Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Corneal Graft Rejection Drug Market Share by Type in 2019
Figure 85. Asia Pacific Corneal Graft Rejection Drug Market Share by Application in 2019
Figure 86. Latin America Corneal Graft Rejection Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Corneal Graft Rejection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Corneal Graft Rejection Drug Sales Market Share by Country in 2019
Figure 89. Latin America Corneal Graft Rejection Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Corneal Graft Rejection Drug Market Share by Type in 2019
Figure 97. Latin America Corneal Graft Rejection Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Corneal Graft Rejection Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Corneal Graft Rejection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Corneal Graft Rejection Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Corneal Graft Rejection Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Corneal Graft Rejection Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Corneal Graft Rejection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Corneal Graft Rejection Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Corneal Graft Rejection Drug Market Share by Application in 2019
Figure 110. North America Corneal Graft Rejection Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Corneal Graft Rejection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Corneal Graft Rejection Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Corneal Graft Rejection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Corneal Graft Rejection Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Corneal Graft Rejection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Corneal Graft Rejection Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Corneal Graft Rejection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Corneal Graft Rejection Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Corneal Graft Rejection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

---